Unternehmen BioPlus Acquisition Corp. Nasdaq
Aktien
A3C8YB
KYG112171098
BIOSU
Holdinggesellschaften
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Ross Haghighat
CEO | Chief Executive Officer | 60 | - |
Corporate Officer/Principal | 53 | - | |
Steven Fletcher
PRN | Corporate Officer/Principal | 56 | - |
Alex Serge Vieux
PRN | Corporate Officer/Principal | 66 | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Stephen Sherwin
BRD | Director/Board Member | 75 | 01.12.21 |
Jonathan Rigby
CHM | Chairman | 56 | 01.07.21 |
Louis Lange
BRD | Director/Board Member | 72 | 01.12.21 |
Ronald Eastman
BRD | Director/Board Member | 71 | 01.12.21 |
Ross Haghighat
CEO | Chief Executive Officer | 60 | - |
Shawn Cross
BRD | Director/Board Member | 56 | 01.12.21 |
Glen Giovannetti
BRD | Director/Board Member | 61 | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 5 750 000 | 0 | 0 | 29,61 % |
Aktie B | 1 | 19 367 477 | 7 437 478 ( 38,40 %) | 0 |
Unternehmenskontakt
BioPlus Acquisition Corp.
260 Madison Avenue Suite 800
10016, New York
+
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+181,49 % | 6,73 Mrd. | |
+18,11 % | 1,17 Mrd. | |
+2,19 % | 982 Mio. | |
+41,91 % | 872 Mio. | |
+22,24 % | 799 Mio. | |
+8,62 % | 675 Mio. | |
+1,72 % | 664 Mio. | |
+43,66 % | 654 Mio. | |
-.--% | 600 Mio. |